Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Timothy M Dempsey"'
Autor:
Michelle B. Herberts, Taylor T. Teague, Viengneesee Thao, Lindsey R. Sangaralingham, Henry J. Henk, Kevin T. Hovde, Timothy M. Dempsey, Andrew H. Limper
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Objective Create a timeline of diagnosis and treatment for IPF in the US. Design, setting, and participants A retrospective analysis was performed in collaboration with the OptumLabs Data Warehouse using an administrative claims database of
Externí odkaz:
https://doaj.org/article/8c2efb01c823433fb7b1a30a45eaa060
Autor:
Taylor T. Teague, Stephanie R. Payne, Bryan T. Kelly, Timothy M. Dempsey, Rozalina G. McCoy, Lindsey R. Sangaralingham, Andrew H. Limper
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with high morbidity and limited treatment options. Type 2 diabetes mellitus (T2DM) is a common comorbid illness among patients with IPF and is often treated
Externí odkaz:
https://doaj.org/article/f0738d2350ab4e4f8175e11f36f6a9c2
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Background The anti-fibrotic medications nintedanib and pirfenidone were approved in the United States for use in patients with idiopathic pulmonary fibrosis several years ago. While there is a growing body of evidence surrounding their clinical effe
Autor:
Andrew H. Limper, Stephanie Payne, Lindsey R. Sangaralingham, Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Nilay Shah, Teng Moua, T. Teague
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nint
Autor:
Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah, Andrew H. Limper
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medicati
Externí odkaz:
https://doaj.org/article/510e1e63fe4a474d9de59209fad2fdef